There's a New Drug for Postpartum Depression and it is EXPENSIVE

The video discusses maternal depression, affecting one in seven women post-birth, and introduces Brexanolone, a new drug targeting hormonal systems, offering faster relief than traditional antidepressants. Despite its efficacy, the drug is costly at $34,000 and requires a 60-hour monitored infusion, posing challenges for new mothers. Side effects include passing out, and its impact on breastfeeding is uncertain. The video highlights ongoing debates about the drug's pros and cons.

Discuss the challenges and considerations for new mothers regarding the treatment of postpartum depression.

What are the administration requirements and potential side effects of Brexanolone?